Biotechnology News

October 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ: XLRN) will provide a corporate update at the Nomura Biotechnology Conference and the Credit Suisse 2014 Healthcare Conference in November.

October 29, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals will report its financial results for the 3rd quarter 2014, on November 6, 2014 prior to a conference call scheduled at 8:30 a.m. EST.

October 29, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the third quarter and nine months ending September 30, 2014.

October 29, 2014

SAN DIEGO--(BUSINESS WIRE)--SynteractHCR attends the Thirteenth Annual Partnerships in Clinical Trials Congress in Europe to interact with international thought leaders and increase its presence as a global CRO.

October 29, 2014

YAVNE, Israel--(BUSINESS WIRE)--MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release...

October 29, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for the third quarter of 2014. “We enter the fourth quarter with strong momentum, and on the threshold of multiple data readouts for one of the most exciting...

October 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics Appoints Manuel C. Aivado, M.D., Ph.D., as Chief Medical Officer and Donna M. Jarlenski as Vice President of Clinical Operations

October 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug

October 29, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Initiation of I-SPY 2 TRIAL of Ganetespib in Breast Cancer

October 29, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: THIRD QUARTER OF 2014 • NET SALES amounted to MSEK 37.1 (24.1). • OPERATING PROFIT totalled MSEK 9.0 (4.5). • PROFIT AFTER TAX amounted to MSEK 7.1 (3.7). • PROFIT AFTER TAX PER SHARE was SEK 0.77 (...

October 29, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext; TNG) today announced its upcoming events calendar for the fourth quarter of 2014. Jefferies Global Healthcare Conference: Transgene will give a corporate...

October 29, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today reported its sales for the third quarter and first nine months of 2014. Unaudited IFRS consolidated sales     3rd quarter Nine months   (in million euros) 2014  ...

October 28, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. Announces Private Offering of Convertible Senior Notes

October 28, 2014

FREMONT, Calif.--(BUSINESS WIRE)--The Thermo Scientific DRI Hydrocodone/Hydromorphone Assay is a homogeneous enzyme immunoassay that specifically detects hydrocodone and major metabolites in human urine.

October 28, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended September 30, 2014. Total revenues for the third quarter of 2014 increased to $6.04 billion compared to $2....

October 28, 2014

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for...

October 28, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

October 28, 2014

BOSTON--(BUSINESS WIRE)--Vertex reported financial results for the quarter ended September 30, 2014.

October 28, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE® (Sirolimus) tablets in the US market on October 27...

October 28, 2014

LEE’S SUMMIT, Mo.--(BUSINESS WIRE)--Acceleration, today announced their attendance at the forthcoming 2014 AAPS Annual Meeting and Exposition November 2nd - 6th in San Diego, CA, USA.

October 28, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced the presentation of the results of the pivotal Phase III clinical trial of the investigational hemostatic agent RAPLIXA™ (fibrin sealant), formerly known as...

October 28, 2014

VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com) (the "Company" or "ProtoKinetix") announces that it has terminated and revoked...

October 28, 2014

MILFORD, Mass.--(BUSINESS WIRE)--The Proteomics and Metabolomics Facility at Colorado State University joins the Waters Centers of Innovation Program.

October 28, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced the company will be presenting and exhibiting at the MD&M Minneapolis Conference 2015. October 29, 2014, 1:30 p.m. –...

October 28, 2014

LOWER GWYNEDD, Pa.--(BUSINESS WIRE)--Richman Chemical announced today that its President and Founder, Ed Richman, has been appointed to serve on the Board of Overseers of the Chemical Heritage Foundation.

October 28, 2014

ASHEVILLE, N.C.--(BUSINESS WIRE)--Cell culture scientists working with sensitive cultures such as stem and primary cells, can turn to a new CO2 incubator that combines the latest technologies for optimal cell growth and contamination control...

October 28, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth to Sponsor Pancreatic Cancer Action Network’s PurpleStride Houston 2014

October 28, 2014

PLANEGG, Germany--(BUSINESS WIRE)--Biomax offers its PEDANT technology in Illumina’s BaseSpace Apps store. The new PEDANT app lets users easily analyze DNA sequences with Biomax’s enterprise-scale Pedant-Pro Sequence Analysis Suite.

October 28, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a global full-service contract research organization, will be in attendance at the upcoming 13th Annual Partnerships in Clinical Trials Congress on 5-6 November 2014.

October 28, 2014

ASHEVILLE, N.C.--(BUSINESS WIRE)--A new series of blast freezers provide researchers with a versatile and flexible sample preparation device for use prior to cold storage. The XBF40D-MD will be displayed this week at the AABB Annual Meeting on...

October 28, 2014

TORONTO & SAN DIEGO--(BUSINESS WIRE)--Triphase Accelerator Corporation, a private, drug development company dedicated to advancing novel compounds through Phase II proof-of-concept, today announced an expansion of its strategic collaboration...

October 28, 2014

TORONTO & SAN DIEGO--(BUSINESS WIRE)--Triphase Accelerator Corporation, a private, drug development company dedicated to advancing novel compounds through Phase II proof-of-concept, today announced a new strategic collaboration with Celgene...

October 28, 2014

DAEJEON, Korea, TORONTO & SAN DIEGO--(BUSINESS WIRE)--PharmAbcine, a private biotechnology company focused on the discovery and development of novel bi-specific antibodies, today announced a new global licensing deal with Triphase Accelerator...

October 28, 2014

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has signed an agreement to purchase substantially all of the assets of Impact Instrumentation...

October 28, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics today announced the appointment of Marsha H. Fanucci to the company’s Board of Directors. She will also serve as Chair of FORMA’s Audit Committee.

October 28, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. (previously known as EnVivo Pharmaceuticals, Inc.), a biopharmaceutical company singularly focused on the development and delivery of innovative medicines to treat serious brain...

October 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Raze Therapeutics appoints Mikel Moyer, PhD, as Vice President, Molecular Discovery.

October 28, 2014

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) announced that its Board of Directors unanimously approved on October 22, 2014 the repurchase of up to $5 million of its common stock. The authorized repurchases will be made from...

October 28, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that its Board of Directors has approved a $0.05 per share cash dividend to be distributed on November 14, 2014, to shareholders of record as of November 7, 2014.

October 28, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. and the U.S. Army Research Institute of Environmental Medicine’s (USARIEM) Military Nutrition Division announced today they are entering into a partnership to examine KineMed’s platform...

October 28, 2014

SKANEATELES, N.Y. & WASHINGTON--(BUSINESS WIRE)--Welch Allyn and Gentag, Inc. announced today that they have entered into a strategic development agreement. The companies will bring to market near field communication technology for medical...

October 28, 2014

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., a leading agriculture technology company headquartered in Illinois, announced today it has received a 2014 State of Illinois Governor’s Export Award for Agricultural Business Exporter. The Governor’s...

October 28, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One announced an agreement with Intermountain Healthcare to provide clinical interpretation to as a key component of Intermountain’s precision medicine services for oncology.

October 28, 2014

CHICAGO--(BUSINESS WIRE)--GTCR Announces Sale of Devicor Medical Products

October 28, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Optum and Alere today announced that Optum has entered into a definitive agreement to acquire Alere Health and its subsidiaries, which provide leading condition management, case management, wellbeing, wellness and...

October 28, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Depomed, Inc. has streamlined its promotional material review process and increased efficiency by replacing its Excel-based system with Veeva Systems’ Vault PromoMats.

October 28, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), today reported business highlights for the quarter ended September 30, 2014. The Company operates in two primary markets - wearable medical technology and point-of...

October 28, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) reported financial results for third-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting...